Trial intelligence / Profile preview

Jie-Gu-Qi-Li tablets after surgery for ankle fracture

ChiCTR2000031362Phase 4Recruiting

Sponsor
Shanghai Sixth People's Hospital East Campus
Start
Mar 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of jiegu qili in ankle fracture (2 arms), sponsored by Shanghai Sixth People's Hospital East Campus. Primary endpoints: AOFAS ankle-hindfoot score and Fracture healing. Started Mar 2020; status: recruiting.

02

Drugs

jiegu qili
03

Conditions

ankle fracture

Beyond the preview

Go deeper on ChiCTR2000031362.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000031362.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call